Search - tctmd.com

Displaying 121 - 140 of 142

Sort: Relevancy | Date

Presentation TCT 2017

TAVR vs SAVR: What Do the 2017 ESC Guidelines Say?

Presenter: Jeroen J. Bax, Axel Linke, Alec S. Vahanian

October 29, 2017

News Industry News TCT 2016

Patients With Sever Aortic Stenosis And Intermediate Surgical Risk Show Similar Late Quality of Life Outcomes Following Either Transcatheter or Surgical Aortic Valve Replacement

November 01, 2016

Presentation TCT 2016

TCT 36: Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement, Cut Points and Relationship With Outcomes: An Analysis of the Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized Trial

Presenter: Charles J. Davidson, Michael J. Reardon, Philip Green

October 31, 2016

Presentation TCT 2016

TCT 35: Predictors of Early Aortic Valve Rehospitalization Following Self-Expanding Transcatheter Aortic Valve Replacement: Results From the CoreValve US Trial Program

Presenter: Charles J. Davidson, Michael J. Reardon, James B. Hermiller Jr.

October 31, 2016

Title Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

Presentation TCT 2016

TCT 34: Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

Presenter: Charles J. Davidson, Michael J. Reardon, Suzanne Baron

October 31, 2016

Presentation TCT 2016

TCT 33: Predictors of Hospital Readmissions After Transcatheter Aortic Valve Replacement

Presenter: Charles J. Davidson, Michael J. Reardon, James Harvey

October 31, 2016

Presentation TCT 2016

Case #1. Post-SAVR Paravalvulular Leak

Presenter: Eulogio J. Garcia, E. Murat Tuzcu

October 30, 2016

News Opinion Editor's Corner TCT 2015

My Takeaways From TCT 2015

Shelley Wood

October 20, 2015

News Conference News TCT 2015

Updates to CoreValve Extreme Risk Study Encouraging

October 13, 2015

News Conference News TCT 2015

Symposia Highlights Variances Between Guideline-Based, ‘Real-World’ Indications for TAVR

October 11, 2015

News Features TCT 2014

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Todd Neale

October 24, 2014

News Conference News TCT 2014

Capture Devices Hold Promise for Decreasing TAVR-Related Stroke

September 15, 2014

News Conference News TCT 2014

Lively Debate on Use of TAVR for Lower-Risk Patients

September 14, 2014

Presentation TCT 2014

Outcomes of TAVR and SAVR: Argentinean Registries

Presenter: Alejandro O. Palacios, Ernesto M. Torresani, Miguel Oscar Payaslian

September 13, 2014

News Conference News TCT 2014

TAVR Effective in High-Risk Patients at ‘Acceptable’ Cost

Todd Neale

September 13, 2014

News Conference News TCT 2013

TAVR a Viable Option for Intermediate-Risk Patients

November 05, 2013

News Conference News TCT 2013

TAVR, Surgical AVR Patients Show Similar Rates of Neurological Damage

November 03, 2013

News Conference News TCT 2013

Two Trials to Assess TAVR in Moderate-Risk Patients

October 30, 2013

Presentation TCT 2013

SAVR

Presenter: Craig Smith

October 28, 2013

Presentation TCT 2012

SAVR Still the Way for Most!

Presenter: Lars Svensson

October 23, 2012

Advertisement

TAVR vs SAVR: What Do the 2017 ESC Guidelines Say?

Patients With Sever Aortic Stenosis And Intermediate Surgical Risk Show Similar Late Quality of Life Outcomes Following Either Transcatheter or Surgical Aortic Valve Replacement

TCT 36: Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement, Cut Points and Relationship With Outcomes: An Analysis of the Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized Trial

TCT 35: Predictors of Early Aortic Valve Rehospitalization Following Self-Expanding Transcatheter Aortic Valve Replacement: Results From the CoreValve US Trial Program

TCT 34: Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

TCT 33: Predictors of Hospital Readmissions After Transcatheter Aortic Valve Replacement

Case #1. Post-SAVR Paravalvulular Leak

My Takeaways From TCT 2015

Updates to CoreValve Extreme Risk Study Encouraging

Symposia Highlights Variances Between Guideline-Based, ‘Real-World’ Indications for TAVR

Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease

Capture Devices Hold Promise for Decreasing TAVR-Related Stroke

Lively Debate on Use of TAVR for Lower-Risk Patients

Outcomes of TAVR and SAVR: Argentinean Registries

TAVR Effective in High-Risk Patients at ‘Acceptable’ Cost

TAVR a Viable Option for Intermediate-Risk Patients

TAVR, Surgical AVR Patients Show Similar Rates of Neurological Damage

Two Trials to Assess TAVR in Moderate-Risk Patients

SAVR

SAVR Still the Way for Most!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content